| Bristol-Myers Squibb SA - Camzyos 2.5 mg, Hartkapseln | | 68477 | | 01 | | Camzyos 2.5 mg | | Hartkapseln | | C01EB24 | | | | 25.04.2023 | | |
| | Composition | | mavacamtenum 2.5 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 0.525 mg. | | Packungsbestandteile | | Capsules | | | | | | | | | BAG: Active Agent | Dose |
|---|
| | 2.5 mg |
| | | | Inactive agents | | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | Hypromellosum | | | | | | | | | | Drucktinte | | | | | | Mannitol | | | | Propylenglycol | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 | 1322.66 | 1454.90 | B | SL | No |
|
|
